Monitoring systemic lupus erythematosus in standard clinical care.
Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease with a fluctuating and unpredictable course. Monitoring SLE in the routine clinic setting is a challenge because both the disease and its treatment can result in organ damage. Disease activity indices and a cumulative history summary can be used to track complicated patients over time. Monitoring guidelines for damage from the disease and for the toxicity of treatment are available.
Petri
Michelle
M
Johns Hopkins University School of Medicine, 1830 E Monument St Suite 7500, Baltimore, MD 21205, USA. mpetri@jhmi.edu
D003625:Data Collection; D019468:Disease Management; D005938:Glucocorticoids / Q000009:adverse effects; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000188:drug therapy / Q000628:therapy*; D008499:Medical Records; D010808:Physical Examination; D011241:Prednisone / Q000009:adverse effects; D011788:Quality of Life
D005938:Glucocorticoids; D011241:Prednisone